The Clorox Company

NYSE:CLX

Household & Personal Products

Consumer Defensive
$108.39 -2.60%

-$2.54 today

Market cap
$13.13B
Beta
0.55
P/E (TTM)
15.2
EPS (TTM)
$6.23
Dividend yield
5.22%
52W Low $84.70High $132.03

Volume 2.16M

Average 2.84M

CLX Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

The Clorox CompanyNYSE: CLX

Investing Cash Flow · Q1 FY2027 · quarter ended Sep 2026

Investing cash flow grows, but more slowly than its trailing trend

Q1 FY2027 investing cash flow of $35M (cash outflow) rose 2.9% year over year, behind the +960.8% change in trailing-twelve-month investing cash flow. Sequentially, it fell 98.4% from the prior quarter. Over 3 fiscal years it compounded at +117.7% a year.

Context

  • Investing cash flow amounted to 34.2% of revenue in FY2026, up 32.9 pp from a year earlier.
  • Investing cash flow grew in size in 1 of the last 3 fiscal years.
  • FY2026 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.9% toward the trailing-twelve-month pace of +960.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$35M-98.4% QoQ
Last fiscal yearJun 2026
-$2.3B+2347.9% YoY
LTMSep 2026
-$2.3B+960.8% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.9%——
1 year+2347.9%——
3-year CAGR+117.7%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2026
(2.3B) USD
Year-over-year change
-2347.9%

Investing Cash Flow vs competitors

How CLX compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +960.8% is the 2nd highest of 10, against a peer median of +7.2%.
  • Investing cash flow amounts to 32.0% of revenue for CLX, versus a peer median of 4.8%.
CLX Competitors
Investing Cash Flow for CLX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PGThe Procter & Gamble CompanyLTM Sep 2026$4.55B USD+7.2%+9.7%5.2%
KMBKimberly-Clark CorporationLTM Jun 2026$3.44B USD+9466.7%+6.6%20.8%
ULUnilever PLCFY2025€3.12B EUR+398.9%—6.2%
CLXThe Clorox CompanyLTM Sep 2026$2.3B USD+960.8%+117.7%32.0%
CLColgate-Palmolive CompanyLTM Sep 2026$484M USD-39.0%-20.1%2.3%
KVUEKenvue Inc.LTM Sep 2026$399M USD-19.1%+3.8%2.6%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$294.3M USD-61.8%-5.4%4.7%
EPCEdgewell Personal Care CompanyLTM Mar 2026$275.2M USD+463.5%-41.0%13.1%
REYNReynolds Consumer Products Inc.LTM Jun 2026$183M USD+21.2%+7.9%4.8%
SPBSpectrum Brands Holdings, Inc.LTM Jun 2026$39.7M USD-135.8%-52.9%1.4%
HELEHelen of Troy LimitedLTM Dec 2025$34.43M USD—-52.4%—
Peer median (excluding CLX) —+7.2%-5.4%4.8%

Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Net Income471M161M292M824M601M
Depreciation & Amortization224M236M235M219M247M
Deferred Income Tax5M(149M)(100M)(18M)81M
Stock-Based Compensation52M73M74M81M48M
Change in Working Capital(99M)354M(241M)(211M)118M
Accounts Receivables(84M)(13M)(34M)(145M)151M
Inventory(18M)58M55M63M(71M)
Accounts Payables(47M)157M(140M)(124M)38M
Other Working Capital50M152M(122M)(5M)0
Other Non-Cash Items133M483M435M86M(483M)
Operating Cash Flow786M1.16B695M981M612M
Capital Expenditures(251M)(228M)(212M)(220M)(207M)
Acquisitions (Net)0017M128M(2.1B)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities22M5M20M(2M)10M
Investing Cash Flow(229M)(223M)(175M)(94M)(2.3B)
Debt Repayment(83M)(188M)(45M)02.57B
Common Stock Issued5M33M1M26M(23M)
Common Stock Repurchased(25M)00(332M)(256M)
Dividends Paid(571M)(583M)(595M)(602M)(602M)
Other Financing Activities(15M)(15M)(16M)(16M)(16M)
Financing Cash Flow(689M)(753M)(655M)(924M)1.67B
Effect of Forex Changes(6M)2M(26M)2M(2M)
Net Change in Cash(138M)184M(161M)(35M)(23M)
Free Cash Flow535M930M483M761M405M

The Clorox Company

NYSE:CLX

Intrinsic Alpha fair value

Locked

Current Price

$108.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.